98 results
424B4
BIXT
Bioxytran, Inc
2 Oct 23
Prospectus supplement with pricing info
11:36am
: source of animals, the nature of tissue used and manufacturing process. We will comply with, and believe we will exceed, all current guidelines … , to deliver a standardized risk disclosure document prepared by the SEC, that: (a) contains a description of the nature and level of risk in the market
424B4
uwr4 m2lnf
14 Aug 23
Prospectus supplement with pricing info
8:07pm
8-K
EX-10.76
l2903td
12 Jun 23
Entry into a Material Definitive Agreement
6:11am
D
qoqi3 pnx7
16 Aug 22
$600K in equity, sold $600K, 1 investor
5:13pm
8-K
EX-99.1
5ue9a7d73lwqt4jolc
1 Aug 22
Other Events
10:49am